Chicago, ILNCT06684522Now EnrollingIRB Ready

Eyelid Dermatitis Clinical Trial in Chicago, IL

Access cutting-edge eyelid dermatitis treatment through this early phase 1 clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Northwestern University

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access eyelid dermatitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related eyelid dermatitis treatment provided free

Apply for This Chicago Location

Check if you qualify for this eyelid dermatitis clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Eyelid Dermatitis Study in Chicago

This study aims to assess the efficacy of upadacitinib in eyelid dermatitis that has not resolved with topical therapies and patch testing.

Sponsor: Northwestern University

Who Can Participate

Inclusion Criteria

Individuals age 18-70 years old with eyelid dermatitis for at least two months
Failure of at least one topical prescription cream for the eyelid dermatitis (steroid, pimecrolimus, tacrolimus, crisaborole, or ruxolitinib)
Women of reproductive potential must agree to using effective contraception during treatment and for 4 weeks following the final dose of Upadacitinib.
Willing and able participants that provide informed consent
Willing and able participants that comply with study activities

Exclusion Criteria

Self-reported history of allergic response to upadacitinib
Subject with self-reported history of heart disease, stroke, or neurological conditions
Currently taking topical medications for eyelid dermatitis within one week of starting study drug
Women who are pregnant, nursing, or who may become pregnant during the study
Non-English-speaking subjects
Patients with an active serious infection
Patients with active TB or latent TB, patients should be tested for TB prior to upadacitinib treatment.
Patients with active HBV/HCV or abnormal lab ranges, Lab Data: Hb\<8g/dL, ALC\<500 cells/mm3 and ANC \<1000 cells/mm3
Patients with a history of malignancy within the last 5 years other than successfully treated NMSC.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06684522) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Eyelid Dermatitis Treatment Options in Chicago, IL

If you're searching for eyelid dermatitis treatment options in Chicago, IL, this clinical trial (NCT06684522) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced eyelid dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all eyelid dermatitis clinical trials near you to find additional studies recruiting in your area.

More Atopic Dermatitis Trials in Chicago, IL

See all atopic dermatitis clinical trials recruiting in Chicago — not just this study.

Browse Atopic Dermatitis Trials in Chicago →

Browse More Trials by Condition

Atopic Dermatitis TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL